Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.435 USD | +8.75% | -1.33% | +38.83% |
15/05 | Brookline Capital Upgrades Dare Bioscience to Buy From Hold, Price Target is $3 | MT |
14/05 | Transcript : Daré Bioscience, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.83% | 40.23M | |
+59.89% | 62.59B | |
-2.96% | 41.18B | |
+44.53% | 40.29B | |
-8.29% | 27.9B | |
+12.49% | 26.21B | |
-21.73% | 19.09B | |
+5.88% | 13.08B | |
+24.50% | 12.26B | |
+27.44% | 12.05B |
- Stock Market
- Equities
- DARE Stock
- News Daré Bioscience, Inc.
- Transcript : Daré Bioscience, Inc., Q2 2021 Earnings Call, Aug 12, 2021